Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2025-12-24 @ 6:41 PM
Study NCT ID:
NCT06685757
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2024-11-11
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)
Sponsor:
Biogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-03
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-11
First Submit QC Date:
None
Study First Post Date:
2024-11-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-23
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL